Sanofi’s Ketek Gets December Advisory Committee Review

Two-day meeting expected to focus on safety issues related to the antibiotic, which has been associated with liver injury.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet